HSPB8 and amyotrophic lateral sclerosis: With this system, we found that colchicine [a Food and Drug Administration (FDA)- and European Medicine Agency (EMA)-approved drug] stimulates HSPB8 expression and enhances the autophagy clearance of the insoluble TDP-43 species (Crippa et al., 2016a) in models of ALS.